Buy Millendo Therapeutics Inc Stock | MLND Stock Price & Latest News | Public
MLND

Millendo Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap
    View Millendo Therapeutics Inc (MLND) stock trends here

    About MLND

    Millendo Therapeutics, Inc. engages in the development of treatments for orphan endocrine diseases. Its product pipeline includes Livoletide (AZP-531) for the treatment of Prader-Willi syndrome; Nevanimibe for classic congenital adrenal hyperplasia; and Neurokinin 3 rec...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.37
    -0.56
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.34

    Actual EPS
    Q1 2021

    Stats

    Market Cap$37,8M
    Volume36,1k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.88
    1 Year Low$1.26
    Open$1.95
    High$2.04
    Low$1.92

    Buy any stock with any amount of money.

    Download the App
    Download the app